From concerning statistics on global health outcomes to new insights on AI and RWD, explore the top pharma news from July ...

Thermo Fisher Scientific is a global science and diagnostics company serving pharmaceutical, biotechnology, healthcare, academic, and government customers. It is known for instruments, chemicals, and ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

Press Release Paris, 29th July 2025 7% to 9% 2025 Core EBITDA margin guidance reaffirmed, with ambition to be in the upper part of the range, supported by thorough execution of the FOCUS-27 plan, and ...

Multiple myeloma pathogenesis is marked by incredibly complex processes that range beyond primary or acquired genetic alterations, with factors in the ...

Talaria’s unique strategy harvests income from market volatility while preserving capital via valuation discipline.

Artbio, a US biotech specializing in radiopharmaceuticals, has raised $132 million in a series B financing to move its lead ...

US pharma giant Pfizer has criticized the recent inclusion of the company in the list of enterprises that should be denied ...

The inaugural flight to Abu Dhabi is part of Ethiopian Airlines’ broader strategy to expand its global network and reinforce ...

The platform elevates institutional funds into composable DeFi foundations, fostering true ecosystem-wide interoperability ...

The vaccine maker’s board intends to recommend a pending offer from investment firms Nordic Capital and Permira, which would ...

Against steep odds and well-established paradigms, these four companies have successfully been commercializing their products ...